Enpresil Co 20 mg, 12,5 mg Tablet
PDF Leaflet Revision Date: May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension where fixed combination is preferred.
Dosage (summary)
1 tablet once daily, max 2 tablets once daily if needed.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; can cause fetal harm.
Key Drug Interactions
- Lithium
- NSAIDs
- Potassium-sparing diuretics
Contraindications
- Hypersensitivity to components
- Severe renal impairment
- Anuria
- Angioedema history
- Pregnancy
- Breastfeeding
Common side effects
- Headache
- Cough
- Dizziness
- Fatigue
Counselling Points
- Monitor blood pressure regularly
- Report signs of angioedema
- Avoid potassium supplements
Serious warnings
- Risk of hypotension
- Angioedema
- Renal function impairment
Important Disclaimer
The Enpresil Co 20 mg, 12,5 mg Tablet professional information leaflet below is the property of Unicorn Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
